Integrative therapeutics for ocular surface disorders
- PMID: 39137038
- DOI: 10.1097/ACI.0000000000001024
Integrative therapeutics for ocular surface disorders
Abstract
Purpose of review: Integrative medicine techniques are increasingly accepted into the treatment paradigm for many chronic disorders including eye disease. Over 71% of patients, including 67% of those with eye disorders, use some form of Integrative therapy. Physicians should be well versed in evidence-based therapies to know how to refer patients for the best complimentary care. We highlight the most effective integrative therapeutics from different complementary treatment paradigms to offer a framework for approaching therapy in patients with ocular surface disorders (OSDs).
Recent findings: Lifestyle and behavioral modifications help a proportion of people with OSDs like dry eye disease and allergic conjunctivitis, which are interrelated disorders. Nutrition and supplementation can also play a role in addressing underlying inflammation and improving OSD symptoms. Acupuncture and traditional herbal medicine may also benefit some patients. New technologies offer innovative treatment pathways in the treatment of OSD but require referral to Ocular Surface Treatment Centers.
Summary: Integrative treatment approach for OSD incorporates allopathic medicine, traditional remedies and lifestyle behavioral interventions, Ayurveda and herbal medicine, Nutritional Supplements, Homeopathy, Acupuncture and Chinese Medicine. New cutting-edge technologies offer breakthroughs in difficult to treat ocular surface cases. Collaboration between allergy or otolaryngology offices, complementary practitioners, as well as optometrists and ophthalmologists in Ocular Surface Treatment Centers can offer patients new avenues of treatment.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
- 
    - Wang X, Li C, Wang Y, et al. An intelligent prediction model of epidemic characters based on multi features. CAAI Trans Intell Technol 2024; 9:595–607.
 
- 
    - Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf 2017; 15:276–283.
 
- 
    - Rao SK, Gokhale N, Matalia H, Mehta P. Inflammation and dry eye disease—where are we? Int J Ophthalmol 2022; 15:820–827.
 
- 
    - Mishra G, Tamboli V, Jwala J, K. Mitra A. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Recent Patents Inflamm Allergy Drug Discov [Internet]. 2011; 5:26–36.
 
- 
    - Chigbu DI, Karbach NJ, Abu SL, Hehar NK. Cytokines in allergic conjunctivitis: unraveling their pathophysiological roles. Life (Basel) 2024; 14:350.
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
- Research Materials
 
        